PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
OMER Omeros
- 9.180
- +0.060+0.66%
Close Feb 14 16:00 ET
- 9.140
- -0.040-0.44%
Post 20:01 ET
531.98MMarket Cap-3.99P/E (TTM)
9.430High9.083Low425.14KVolume9.150Open9.120Pre Close3.92MTurnover0.77%Turnover RatioLossP/E (Static)57.95MShares13.60052wk High-3.45P/B508.06MFloat Cap2.61252wk Low--Dividend TTM55.34MShs Float30.230Historical High--Div YieldTTM3.81%Amplitude0.920Historical Low9.224Avg Price1Lot Size
About Omeros Company
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Company Profile
SymbolOMER
Company NameOmeros
Listing DateOct 8, 2009
Issue Price10.00
Founded1994
CEODr. Gregory A. Demopulos,M.D.
MarketNASDAQ
Employees198
Fiscal Year Ends12-31
AddressThe Omeros Building,201 Elliott Avenue West
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98119
Phone1-206-676-5000
Websitehttp://www.omeros.com
Company Executives
- Name
- Position
- Salary
- Dr. Gregory A. Demopulos,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 7.69M
- Dr. George A. Gaitanaris, M.D.,PhD
- Vice President, Science and Chief Scientific Officer
- --
- Nadia Dac
- Vice President and Chief Commercial Officer
- --
- Dr. Catherine A. Melfi, PhD
- Vice President, Regulatory Affairs and Quality Systems and Chief Regulatory Officer
- --
- Dr. Andreas Grauer, M.D.
- Vice President and Chief Medical Officer
- --
- David J. Borges
- Vice President, Finance, Chief Accounting Officer, Principal Financial Officer and Treasurer
- --
- Peter W. Williams
- Vice President, Human Resources
- --
- Dr. Mariana N. Dimitrova
- Vice President, Chemistry, Manufacturing and Controls
- --
- Dr. J. Whitaker, J.D.,M.D.
- Vice President, Clinical Development
- --
- Peter B. Cancelmo
- Vice President, General Counsel and Corporate Secretary
- 852.63K
- Dr. Peter A. Demopulos,M.D.
- Director
- 122.60K
- Diana T. Perkinson
- Director
- 174.66K
- Dr. Rajiv Shah, M.D.
- Independent Director
- 140.10K
- Thomas J. Cable
- Lead Independent Director
- 177.60K
- Dr. Thomas F. Bumol, PhD
- Independent Director
- 127.60K
- Arnold C. Hanish
- Independent Director
- 137.60K
- Dr. Leroy E. Hood,M.D.,Ph.
- Independent Director
- 135.10K
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!